BiotechCROPharmaceuticalPre-ClinicalRegulatory SubmissionRegulatory SubmissionsSENDSEND Advantage ServicesSensible SEND
There is nothing permanent except change
Marc Ellison
SEND keeps changing fast. Recently, FDA made it clear that SEND requirements go beyond just studies placed in the eCTD, if a study can be represented in SEND, it should be. This broadens the scope...
